JP2022526651A5 - - Google Patents
Info
- Publication number
- JP2022526651A5 JP2022526651A5 JP2021559800A JP2021559800A JP2022526651A5 JP 2022526651 A5 JP2022526651 A5 JP 2022526651A5 JP 2021559800 A JP2021559800 A JP 2021559800A JP 2021559800 A JP2021559800 A JP 2021559800A JP 2022526651 A5 JP2022526651 A5 JP 2022526651A5
- Authority
- JP
- Japan
- Prior art keywords
- integer
- independently
- appearing
- compound according
- bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024152056A JP2025000633A (ja) | 2019-04-11 | 2024-09-04 | プログラム可能なポリマー薬 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962832728P | 2019-04-11 | 2019-04-11 | |
| US62/832,728 | 2019-04-11 | ||
| US201962877160P | 2019-07-22 | 2019-07-22 | |
| US62/877,160 | 2019-07-22 | ||
| PCT/US2020/027758 WO2020210694A1 (en) | 2019-04-11 | 2020-04-10 | Programmable polymeric drugs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024152056A Division JP2025000633A (ja) | 2019-04-11 | 2024-09-04 | プログラム可能なポリマー薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526651A JP2022526651A (ja) | 2022-05-25 |
| JP2022526651A5 true JP2022526651A5 (https=) | 2024-07-11 |
| JP7551060B2 JP7551060B2 (ja) | 2024-09-17 |
Family
ID=70482851
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559800A Active JP7551060B2 (ja) | 2019-04-11 | 2020-04-10 | プログラム可能なポリマー薬 |
| JP2024152056A Pending JP2025000633A (ja) | 2019-04-11 | 2024-09-04 | プログラム可能なポリマー薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024152056A Pending JP2025000633A (ja) | 2019-04-11 | 2024-09-04 | プログラム可能なポリマー薬 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220168435A1 (https=) |
| EP (1) | EP3952918A1 (https=) |
| JP (2) | JP7551060B2 (https=) |
| KR (1) | KR20210152522A (https=) |
| CN (2) | CN114072178A (https=) |
| WO (1) | WO2020210694A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| KR102646956B1 (ko) | 2015-02-26 | 2024-03-14 | 소니그룹주식회사 | 페닐에티닐나프탈렌 염료 및 이의 사용 방법 |
| US11827661B2 (en) | 2015-02-26 | 2023-11-28 | Sony Group Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| CN107709470B (zh) | 2015-05-11 | 2021-01-29 | 索尼公司 | 超亮二聚或多聚染料 |
| CN109415574B (zh) | 2016-04-01 | 2021-05-28 | 索尼公司 | 具有刚性间隔基团的超亮二聚体或聚合物染料 |
| AU2017240154B2 (en) | 2016-04-01 | 2021-08-12 | Sony Group Corporation | Ultra bright dimeric or polymeric dyes |
| WO2017177065A2 (en) | 2016-04-06 | 2017-10-12 | Sony Corporation | Ultra bright dimeric or polymeric dyes with spacing linker groups |
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
| EP3455300A1 (en) | 2016-05-11 | 2019-03-20 | Sony Corporation | Ultra bright dimeric or polymeric dyes |
| JP7312929B2 (ja) | 2016-07-29 | 2023-07-24 | ソニーグループ株式会社 | 超明色二量体またはポリマー色素およびその調製のための方法 |
| WO2019071153A1 (en) | 2017-10-05 | 2019-04-11 | Sony Corporation | PROGRAMMABLE DENDRITIC MEDICINES |
| KR20260011205A (ko) | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| CN111836645A (zh) | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| EP3737417B1 (en) | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| CN111565756A (zh) | 2018-01-12 | 2020-08-21 | 索尼公司 | 包含生物活性化合物的具有刚性间隔基团的聚合物 |
| US12539334B2 (en) | 2018-01-12 | 2026-02-03 | Sony Group Corporation | Phosphoalkyl polymers comprising biologically active agents |
| KR102742386B1 (ko) | 2018-03-19 | 2024-12-16 | 소니그룹주식회사 | 형광 신호 향상을 위한 2가 금속의 사용 |
| CN118480073A (zh) | 2018-03-21 | 2024-08-13 | 索尼公司 | 具有连接体基团的聚合串联染料 |
| JP7580689B2 (ja) | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| KR20210032434A (ko) | 2018-07-13 | 2021-03-24 | 소니 주식회사 | 유기인산염 단위를 포함하는 백본을 갖는 중합체성 염료 |
| WO2021062176A2 (en) | 2019-09-26 | 2021-04-01 | Sony Corporation | Polymeric tandem dyes with linker groups |
| EP4038081A1 (en) | 2019-09-30 | 2022-08-10 | Sony Group Corporation | Nucleotide probes |
| EP4256078A1 (en) | 2020-12-07 | 2023-10-11 | Sony Group Corporation | Spacing linker group design for brightness enhancement in dimeric or polymeric dyes |
| CN117750977A (zh) * | 2021-07-22 | 2024-03-22 | 索尼集团公司 | 聚合型药物的自动合成 |
| WO2023002431A1 (en) * | 2021-07-22 | 2023-01-26 | Sony Group Corporation | Automated synthesis of polymeric drugs |
| WO2024110803A1 (en) * | 2022-11-22 | 2024-05-30 | Sony Group Corporation | Polymeric compounds comprising antineoplastic agents |
| KR20260023583A (ko) | 2023-08-31 | 2026-02-20 | 후지필름 가부시키가이샤 | 표적화 약물 복합체 및 이것을 포함하는 의약, 및, 화합물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| US11827661B2 (en) | 2015-02-26 | 2023-11-28 | Sony Group Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| CN107709470B (zh) | 2015-05-11 | 2021-01-29 | 索尼公司 | 超亮二聚或多聚染料 |
| JP6817288B2 (ja) * | 2015-08-10 | 2021-01-20 | ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． | 新規な連結体及び生体分子と薬物との特異的共役におけるその使用 |
| WO2017177065A2 (en) * | 2016-04-06 | 2017-10-12 | Sony Corporation | Ultra bright dimeric or polymeric dyes with spacing linker groups |
| EP3455300A1 (en) | 2016-05-11 | 2019-03-20 | Sony Corporation | Ultra bright dimeric or polymeric dyes |
| KR20260011205A (ko) * | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
-
2020
- 2020-04-10 WO PCT/US2020/027758 patent/WO2020210694A1/en not_active Ceased
- 2020-04-10 US US17/602,718 patent/US20220168435A1/en active Pending
- 2020-04-10 CN CN202080040295.9A patent/CN114072178A/zh active Pending
- 2020-04-10 KR KR1020217036842A patent/KR20210152522A/ko active Pending
- 2020-04-10 EP EP20723676.1A patent/EP3952918A1/en active Pending
- 2020-04-10 CN CN202510194215.XA patent/CN120037399A/zh active Pending
- 2020-04-10 JP JP2021559800A patent/JP7551060B2/ja active Active
-
2024
- 2024-09-04 JP JP2024152056A patent/JP2025000633A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526651A5 (https=) | ||
| JP2022526014A5 (https=) | ||
| JP2022526017A5 (https=) | ||
| US20200247887A1 (en) | Anti-cd79b antibodies and immunoconjugates and methods of use | |
| EP3952917A1 (en) | Programmable polymeric drugs | |
| CN120037399A (zh) | 可编程的聚合药物 | |
| EP3952916A1 (en) | Programmable polymeric drugs | |
| JP2024536224A5 (https=) | ||
| US7378091B2 (en) | Antibodies against carbonic anhydrase IX (CA IX) tumor antigen | |
| CN102580084B (zh) | Her抗体的固定剂量给药 | |
| JP5138867B2 (ja) | α−フェトタンパク質Ｉｍｍｕ３１抗体および融合タンパク質ならびにその使用方法 | |
| JP2024537069A5 (https=) | ||
| JP2021510696A5 (https=) | ||
| IL287292B (en) | and fusion antibody-drug-cd79b engineered antibodies cysteine- | |
| JP2008523073A (ja) | Ｈｅｒ阻害剤を用いた治療のための患者の選択 | |
| NZ583318A (en) | Humanized anti-cd79b antibodies and immunoconjugates and methods of use | |
| JP2012525149A (ja) | ヘテロ多量体分子を作製するための方法 | |
| AU2022287316A9 (en) | Neodegrader conjugates | |
| US20250009786A1 (en) | Automated synthesis of polymeric dual drugs | |
| JP2024532726A5 (https=) | ||
| US20240307548A1 (en) | Enhanced targeting using antibody-oligonucleotide conjugates | |
| WO2024082934A1 (zh) | 酶裂解连接子及包含其的配体-艾瑞布林偶联物 | |
| EP3762037B1 (en) | Releasable antibody conjugates | |
| EP4285936A1 (en) | Antibody-drug conjugate and medical use thereof | |
| CN114605536B (zh) | 降低抗人胸腺基质淋巴细胞生成素单克隆抗体生产中宿主细胞蛋白含量的亲和纯化方法 |